Purchase Order 75N90021P00366
Award Date
4/23/21
Potential Completion Date
4/28/22
Potential Value
$97K
Federal Agency
NIH Clinical Center
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIAID DEA OA Acquisitions) to Illumina, Inc. for sequencing kits to support the Illumina HiSeq 2500 gene sequencing platform. The total award ceiling is $19,450.92, with an ultimate completion date of April 24, 2015. Illumina is a for-profit manufacturer of genetic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from agencies like the NIH, CDC, USDA, and...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a 12-month base period with a 1-year option to provide comprehensive maintenance services for an Illumina HiSeq 2500 sequencing instrument used to diagnose inherited immune disorders. The contract has a ceiling value of $96,921.00 and was awarded on a sole source basis, as...
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The objective is to procure a comprehensive maintenance plan that includes parts, labor, and materials for an Illumina HiSeq 2500 DNA sequencing instrument. The contract has a ceiling value of $442,123.75 and a period of performance through December 22, 2020. Illumina is a manufacturer of genomic sequencing...
This is a firm fixed price service contract awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $411,137.00, provides for the renewal and maintenance of an Illumina HiSeq2500 sequencing system. The contract has no set-aside designation and was awarded on June 7, 2017, with a completion date of December 10,...
This is a firm fixed-price federal purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to the for-profit manufacturer Illumina, Inc. The contract has a ceiling value of $88,110.00 and an ultimate completion date of April 28, 2020. The contract does not have any set-aside designation. Under this contract, Illumina will provide a range of genomic sequencing systems, reagents, consumables, and related services to the NIH, which conducts biomedical and public...
This is a $48,209 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. The contract will support the provision of Illumina's sequencing and array-based solutions for genetic and genomic analysis, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, sample prep kits, and bioinformatics products. The contract does not have a set-aside designation. Illumina has previously provided similar...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing services. The contract has a ceiling value of $95,569.54 and does not include any set-aside provisions. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously received prime federal contracts and grants from agencies including the NIH, Centers...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. for the procurement of an Illumina NextSeq 2000 sequencing system with a trade-in. The total ceiling value of the award is $207,415.25 and the ultimate completion date is October 4, 2024. The contract does not have any set-aside designation. Based on Illumina's background as a manufacturer of genetic and genomic analysis instruments and reagents, this award is likely...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $6,418.66 contract is for the provision of various Illumina sequencing platforms, including NextSeq, NovaSeq, MiSeq, and iSeq systems, along with related consumables, sample preparation kits, and support services. Illumina has previously served as a subcontractor on federal contracts supporting genomic...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...